Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Jul 20;20(7):499-504.
doi: 10.3779/j.issn.1009-3419.2017.07.09.

[Recent Advances in Association of Estrogen and Non-small Cell Lung Cancer]

[Article in Chinese]
Xiaosheng Ding  1 , Chuanhao Tang  1 , Zhijie Wang  1 , Jun Liang  1
Affiliations
Review

[Recent Advances in Association of Estrogen and Non-small Cell Lung Cancer]

[Article in Chinese]
Xiaosheng Ding et al. Zhongguo Fei Ai Za Zhi. .

Abstract
in English, Chinese

Lung cancer, of which approximately 85% are non-small cell lung cancer (NSCLC), is one of the most prevalent cancers and the most leading cause of cancer mortality. Despite recent improvements in its treatment, the prognosis remains dismal. Previous studies have clearly proved that estrogen and estrogen receptors (ER) are involve in the pathogenesis and development of lung cancer. More and more evidences showed antiestrogen therapy may reverse the drug-resistance of platinum based chemotherapy in NSCLC patients and can enhance curative effect of epidermal growth factor receptor tyrosine kinase inhibitor. We will review recent progress in the function of estrogen in NSCLC and the treatment based on the ER signaling pathways for NSCLC in this article.

肺癌是目前发病率及死亡率最高的恶性肿瘤之一，其中约85%为非小细胞肺癌（non-small cell lung cancer, NSCLC）。尽管其治疗手段不断提高，但总体预后不容乐观。既往研究已证实雌激素系统参与了NSCLC的发生、发展。越来越多的证据表明，抗雌激素治疗不仅可以逆转NSCLC患者对铂类化疗药物的耐药性，还可以增加人类表皮生长因子受体酪氨酸激酶抑制剂的疗效。本文就雌激素系统及抗雌激素治疗在NSCLC中的作用作一综述。.

PubMed Disclaimer

References

    1. Beattie CW, Hansen NW, Thomas PA. Steroid receptors in human lung cancer. http://www.sciencedirect.com/science/article/pii/0304383582900143. Cancer Res. 1985;45(9):4206–4214. - PubMed
    1. Niikawa H, Suzuki T, Miki Y, et al. Intratumoral estrogens and estrogen receptors in human non-small cell lung carcinoma. Clin Cancer Res. 2008;14(14):4417–4426. doi: 10.1158/1078-0432.CCR-07-1950. - DOI - PubMed
    1. Papadopoulos A, Guida F, Leffondre K, et al. Heavy smoking and lung cancer: are women at higher risk? Result of the ICARE study. Br J Cancer. 2014;110(5):1385–1391. doi: 10.1038/bjc.2013.821. - DOI - PMC - PubMed
    1. Tang H, Liao Y, Chen G, et al. Estrogen and insulin-like growth factor 1 synergistically promote the development of lung adenocarcinoma in mice. Int J Cancer. 2013;133(10):2473–2482. doi: 10.1002/ijc.28262. - DOI - PubMed
    1. Liu W, Konduri SD, Bansal S, et al. Estrogen receptor-alpha binds p53 tumor suppressor protein directly and represses its function. J Biol Chem. 2006;281(15):9837–9840. doi: 10.1074/jbc.C600001200. - DOI - PubMed

MeSH terms